Golombek, P.; Müller, M.; Barthlott, I.; Sproll, C.; Lachenmeier, D.W.
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature. Toxics 2020, 8, 41.
https://doi.org/10.3390/toxics8020041
AMA Style
Golombek P, Müller M, Barthlott I, Sproll C, Lachenmeier DW.
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature. Toxics. 2020; 8(2):41.
https://doi.org/10.3390/toxics8020041
Chicago/Turabian Style
Golombek, Patricia, Marco Müller, Ines Barthlott, Constanze Sproll, and Dirk W. Lachenmeier.
2020. "Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature" Toxics 8, no. 2: 41.
https://doi.org/10.3390/toxics8020041
APA Style
Golombek, P., Müller, M., Barthlott, I., Sproll, C., & Lachenmeier, D. W.
(2020). Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature. Toxics, 8(2), 41.
https://doi.org/10.3390/toxics8020041